Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.

Item

http://www.wikidata.org/entity/Q48226517

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Oligometastases in prostate ca ...... s after hypofractionated IGRT.

@en

Oligometastases in prostate ca ...... s after hypofractionated IGRT.

@nl

type

Item

label

Oligometastases in prostate ca ...... s after hypofractionated IGRT.

@en

Oligometastases in prostate ca ...... s after hypofractionated IGRT.

@nl

prefLabel

Oligometastases in prostate ca ...... s after hypofractionated IGRT.

@en

Oligometastases in prostate ca ...... s after hypofractionated IGRT.

@nl

P1476

Oligometastases in prostate ca ...... Ts after hypofractionated IGRT

@en

P2093

Fabian Krause

http://www.w3.org/2001/XMLSchema#string

Juergen Dunst

http://www.w3.org/2001/XMLSchema#string

Mark Koncz

http://www.w3.org/2001/XMLSchema#string

Ulf Luetzen

http://www.w3.org/2001/XMLSchema#string

P2860

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.

PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.

111In-capromab pendetide: the evolution of prostate specific membrane antigen and the nuclear imaging of its 111In-labelled murine antibody in the evaluation of prostate cancer.

68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT

Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer.

Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.

P2888

s00066-017-1239-1

P304

318-324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00066-017-1239-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

194

http://www.w3.org/2001/XMLSchema#string

P50

René Baumann

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29181556

http://www.w3.org/2001/XMLSchema#string

P932

5869895

http://www.w3.org/2001/XMLSchema#string